PT2403493T - Composições oftálmicas anti-inflamatórias não esteroides - Google Patents

Composições oftálmicas anti-inflamatórias não esteroides

Info

Publication number
PT2403493T
PT2403493T PT107493801T PT10749380T PT2403493T PT 2403493 T PT2403493 T PT 2403493T PT 107493801 T PT107493801 T PT 107493801T PT 10749380 T PT10749380 T PT 10749380T PT 2403493 T PT2403493 T PT 2403493T
Authority
PT
Portugal
Prior art keywords
steroidal anti
ophthalmic compositions
inflammatory ophthalmic
inflammatory
compositions
Prior art date
Application number
PT107493801T
Other languages
English (en)
Inventor
M Bowman Lyle
Pham Stephen
Hosseini Kamran
C Si Erwin
Original Assignee
Insite Vision Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42678805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2403493(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Insite Vision Incorporated filed Critical Insite Vision Incorporated
Publication of PT2403493T publication Critical patent/PT2403493T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT107493801T 2009-03-05 2010-03-05 Composições oftálmicas anti-inflamatórias não esteroides PT2403493T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/398,657 US8778999B2 (en) 2009-03-05 2009-03-05 Non-steroidal anti-inflammatory ophthalmic compositions

Publications (1)

Publication Number Publication Date
PT2403493T true PT2403493T (pt) 2016-07-07

Family

ID=42678805

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107493801T PT2403493T (pt) 2009-03-05 2010-03-05 Composições oftálmicas anti-inflamatórias não esteroides

Country Status (7)

Country Link
US (1) US8778999B2 (pt)
EP (1) EP2403493B1 (pt)
CA (1) CA2753947C (pt)
DK (1) DK2403493T3 (pt)
ES (1) ES2586064T3 (pt)
PT (1) PT2403493T (pt)
WO (1) WO2010102192A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058581B (zh) * 2010-11-30 2013-01-30 广东宏盈科技有限公司 一种眼用凝胶
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物
US20130023575A1 (en) * 2011-07-22 2013-01-24 Kamran Hosseini Compositions and methods for the treatment of ocular surface allergies
WO2013055856A1 (en) * 2011-10-12 2013-04-18 Bausch & Lomb Incorporated Ocular composition containing bromfenac with increased bioavailability
US20130217657A1 (en) * 2011-12-21 2013-08-22 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
US20130165419A1 (en) * 2011-12-21 2013-06-27 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
WO2013179253A1 (en) * 2012-06-02 2013-12-05 Micro Labs Limited Dose combination comprising nsaid and steroidal anti-inflammatory agent for treating post operative ocular inflammation
WO2014160579A1 (en) * 2013-03-25 2014-10-02 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
EA201591910A1 (ru) * 2013-06-19 2016-05-31 Сентисс Рисерч Центр Стабильный раствор бромфенака
US20170000889A1 (en) * 2013-12-12 2017-01-05 Sentiss Pharma Private Limited Stable bromfenac ophthalmic solution
GR1008921B (el) * 2015-12-10 2017-01-12 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
CN107375207A (zh) * 2017-08-30 2017-11-24 辽宁美滋林药业有限公司 一种溴芬酸钠滴眼液及其制备工艺
US10351602B1 (en) 2018-05-31 2019-07-16 University Of South Florida Antimicrobial analogues of gramicidin S
CN111743858B (zh) * 2019-03-29 2023-06-27 天津药业研究院股份有限公司 一种溴芬酸钠的药物组合物
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
CN112546044B (zh) * 2020-12-23 2022-12-06 广东宏盈科技有限公司 一种噻洛芬酸与异黄酮药物组合物及其应用
CN115006412B (zh) * 2022-05-20 2023-11-10 北京诺康达医药科技股份有限公司 一种复方妥布霉素滴眼液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US4192827A (en) 1974-06-27 1980-03-11 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
US4136250A (en) 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
US4548990A (en) 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
US4546990A (en) * 1983-09-06 1985-10-15 Harriger George A Hydraulic drive system for bicycles and the like
US4910225A (en) 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5221696A (en) * 1989-03-29 1993-06-22 Alcon Laboratories, Inc. Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
US5124154A (en) 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
AU704591B2 (en) * 1994-04-04 1999-04-29 William R. Freeman Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5558876A (en) 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
DE50100416D1 (de) * 2000-01-20 2003-08-28 Mann Gerhard Chem Pharm Fab Diclofenamid suspensionsgel
PL375698A1 (en) * 2002-09-06 2005-12-12 Abbott Laboratories Medical device having hydration inhibitor
JP4500261B2 (ja) * 2003-01-21 2010-07-14 千寿製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤
WO2005041870A2 (en) * 2003-10-24 2005-05-12 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
EP1981491A4 (en) 2006-01-25 2009-09-23 Aciex Inc COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DROUGHT
US20080039398A1 (en) * 2006-01-25 2008-02-14 Ousler George W Iii Formulations and methods for treating dry eye
CA2687717A1 (en) 2007-05-24 2008-12-18 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
WO2013055856A1 (en) 2011-10-12 2013-04-18 Bausch & Lomb Incorporated Ocular composition containing bromfenac with increased bioavailability

Also Published As

Publication number Publication date
US8778999B2 (en) 2014-07-15
US20100227928A1 (en) 2010-09-09
DK2403493T3 (en) 2016-07-18
EP2403493B1 (en) 2016-05-18
EP2403493A2 (en) 2012-01-11
CA2753947C (en) 2017-04-18
WO2010102192A2 (en) 2010-09-10
ES2586064T3 (es) 2016-10-11
CA2753947A1 (en) 2010-09-10
EP2403493A4 (en) 2013-09-18
WO2010102192A3 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
HRP20182200T1 (hr) Nova protuupalna sredstva
PT2403493T (pt) Composições oftálmicas anti-inflamatórias não esteroides
IL215194A0 (en) Novel anti-inflammatory agents
EP2403852B8 (en) 2-aminobenzimidazole-5-carboxamides as anti-inflammatory agents
HRP20150004T1 (en) 2-anilinobenzimidazole-6-carboxamides as anti-inflammatory agents
EP2794008A4 (en) COMBINATION OF ANTI-INFLAMMATORY COMPOSITIONS FOR THE EYE
IL211147A0 (en) 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
EP2598165A4 (en) IMMUNOGENIC INFLAMMATORY COMPOSITIONS
DOP2011000396A (es) Composiciones novedosas
EP2415748A4 (en) NEW INFLAMMATORY COMPOUNDS
ZA201008727B (en) Anti-inflammatory agents
HK1171380A1 (en) Ophthalmic composition
GB0920231D0 (en) Photoresist composition
DOP2011000242A (es) Macrolido anti-inflamatorio
HUE038924T2 (hu) Gyulladásgátló készítmény
EP2499123A4 (en) INFLAMMATORY CONNECTIONS
ZA201208406B (en) Anti-inflammatory agents
AU2009904787A0 (en) Anti-inflammatory agents
GB0901071D0 (en) Anti-inflammatory compounds
GB0906255D0 (en) Sleep-induced ophthalmic composition
AU2009905498A0 (en) Anti-inflammatory compounds
AU2010904345A0 (en) Anti-inflammatory agents